Reptile · Testudo horsfieldii · typical adult weight 0.23–0.91 kg
Cisapride is dosed at 0.5–2 mg/kg PO q24h in russian tortoises, per 63. Carpenter JW, Klaphake E, Gibbons PM, et al. Reptile formulary. In: Divers SJ, Stahl SJ, eds. Mader's Reptile and Amphibian Medicine and Surgery, 3rd ed., Elsevier, St. Louis, MO; 2019:1191-1211. | 469. Tothill A, Johnson J, Branvold H, et al. Effect of cisapride, erythromycin, and metoclopramide on gastrointestinal transit time in the desert tortoise, Gopherus agassizii. J Herpetol Med Surg. 2000;10:16-20. — Source: Carpenter's Exotic Animal Formulary, 6th Ed, p.272 — Carpenter's Exotic Animal Formulary 6th ed, Table 4.11 (Miscellaneous Agents Used in Reptiles). Located 2026-08-05: the only table covering this species in which the drug's own row prints this dose. The copy held is an ebook conversion with no printed page numbers, so the table is the citable location. — SOURCE EDITION: Carpenter's Exotic Animal Formulary — ISBN 9780323833929, https://openlibrary.org/isbn/9780323833929; Mader's Reptile and Amphibian Medicine and Surgery (Divers & Stahl) — ISBN 9780323482530, https://openlibrary.org/isbn/9780323482530. Cisapride is used in russian tortoises for Gastrointestinal stasis (motility modifier). Routes documented in russian tortoises: PO. A typical adult russian tortoise weighs 0.23–0.91 kg. ExoticRx lists 1 cited dose rule for Cisapride in russian tortoises, drawn from published veterinary references. Verify against current literature before clinical use.
US trade names: Propulsid
| Route | Dose | Frequency | Indication | Evidence | Source |
|---|---|---|---|---|---|
| PO | 0.5–2 mg/kg | q24h | Gastrointestinal stasis (motility modifier) | Weak | 63. Carpenter JW, Klaphake E, Gibbons PM, et al. Reptile formulary. In: Divers SJ, Stahl SJ, eds. Mader's Reptile and Amphibian Medicine and Surgery, 3rd ed., Elsevier, St. Louis, MO; 2019:1191-1211. | 469. Tothill A, Johnson J, Branvold H, et al. Effect of cisapride, erythromycin, and metoclopramide on gastrointestinal transit time in the desert tortoise, Gopherus agassizii. J Herpetol Med Surg. 2000;10:16-20. — Source: Carpenter's Exotic Animal Formulary, 6th Ed, p.272 — Carpenter's Exotic Animal Formulary 6th ed, Table 4.11 (Miscellaneous Agents Used in Reptiles). Located 2026-08-05: the only table covering this species in which the drug's own row prints this dose. The copy held is an ebook conversion with no printed page numbers, so the table is the citable location. — SOURCE EDITION: Carpenter's Exotic Animal Formulary — ISBN 9780323833929, https://openlibrary.org/isbn/9780323833929; Mader's Reptile and Amphibian Medicine and Surgery (Divers & Stahl) — ISBN 9780323482530, https://openlibrary.org/isbn/9780323482530 |
Every held source for this drug and species, as printed. Where they differ, both are shown — the choice is yours, not ours.
| Dose (mg/kg) | Route | Source | As printed |
|---|---|---|---|
| 0.5–2 | PO | Carpenter's Exotic Animal Formulary, 6th edTable 4.11 | 0.5-2 mg/kg PO q24h |
| 0.5–2 | PO | Mader's Reptile and Amphibian Medicine and Surgery, 3rd edTable 127.9 | 0.5-2 mg/kg PO q24h99 Most species/motility modifier; gastrointestinal stasis; not commercially available in the United States; may be compounded; ineffective in desert tortoises a |
Figures are transcribed from the cited page or table of each held edition and are shown for reference only. They are not dose recommendations, they do not feed the calculator, and none has been reviewed by a veterinarian.
Need the exact dose for your patient?
These ranges are per kg. Enter your russian tortoise's weight to get the precise dose and draw-up volume — unit and concentration math done for you.
Serotonin 5-HT4 receptor agonist. Enhances acetylcholine release in the myenteric plexus, promoting GI motility throughout the tract.
Withdrawn from human market (cardiac arrhythmias); available as compounded product for veterinary use. Contraindicated with GI obstruction. May interact with azole antifungals.
Species-specific contraindications and adverse-reaction reports for russian tortoises may differ from canine / feline reference data — consult the primary citations listed with each rule.
Cisapride dose range in russian tortoises, with cited source references: PO 0.5–2 mg/kg q24h. Reference ranges from cited sources — verify against current literature before clinical use.
Documented routes for Cisapride in russian tortoises: PO.
Cisapride is indicated in russian tortoises for: Gastrointestinal stasis (motility modifier).
These are general warnings for Cisapride across species; consult the russian tortoise dosing table above for species-specific guidance. Withdrawn from human market (cardiac arrhythmias); available as compounded product for veterinary use. Contraindicated with GI obstruction. May interact with azole antifungals.
Why a species-specific page? Cisapride pharmacokinetics differ across species: dose ranges, intervals, and route preferences are not interchangeable. Cross-extrapolation from canine doses is unsafe in russian tortoises — the rules above are the citations specific to this species, not generic recommendations.
Sourced from published veterinary references; awaiting credentialed clinical reviewer. See our editorial process. Reference only — not veterinary advice.